AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

NVO reports disappointing data from a phase III study on a novel obesity candidate, CagriSema. RHHBY buys rights to obesity candidate from Zealand Pharma.

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now soon they may be unavailable to most.

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Q. I have something like varicose veins in my nose that cause frequent nosebleeds. My nose is often dry regardless of weather conditions.

Ozempic and other similar drugs must be injected. Messer describes the needle as “small, the size of two human hairs.” ...

Two years after she was accused of sexual harassment by three former back-up dancers, Lizzo is launching her musical comeback with a new single.

Novo Nordisk’s NVO stock declined 4.3% on Wednesday after Roche RHHBY announced a license and collaboration deal worth $5.3 ...

A day after announcing a business split-off to focus on weight loss and diabetes implants, Vivani Medical has implanted the ...

Ozempic is a prescription medication used primarily to manage type 2 diabetes and assist with weight loss in certain individuals. Should you depend on this drug for weight loss?

The late TV doctor’s wife Dr Clare Bailey Mosley is also bringing out a cookbook titled Eating Together: A Recipe For ...

COMMENT: The new craze of using lower-than-recommended dosages of weight loss drugs to slim down might sound tempting, says ...